Gnosis by Lesaffre is introducing an updated version of its vitaMK7 natural vitamin K2 with enhanced protection, designed to help manufacturers ensure the stability of complex finished product formulations. The powder is produced using proprietary technology to protect the particles of MK-7 with no coating, no additives, and no additional ingredient, the company says.
“Stability is a constant issue facing commercial partners with the desire to create complex vitamin K2 formulations. Historically our R&D Team has been able to guide them through the process to ensure their products were stable,” says Dr Sophie Legrain-Raspaud, Global Research and Applications Director with Gnosis by Lesaffre. “With vitaMK7 Matrix, that process is now more efficient because the matrix carrier embeds the K2 as MK7 particles in the product, thus leading to products hitting the market much faster.”
Research shows moisture and mineral salts are critical variables for degradation, the company says, driving the need for a protective technology to shelter the menaquinone molecules during shelf life.
The updated product is designed to address these issues, providing a less cumbersome and more predictable formulation process for complex K2 products. It also offers improved homogeneity for easier handling, increased stability with mineral complexes, and facilitates formulas with shorter ingredient lists and no additives.
“This is an important improvement we are excited to share with our commercial partners and the global market,” said Xavier Berger, Global Market Manager at Gnosis by Lesaffre. “Enhancing protection of the MK-7 molecule is an important element for those seeking to explore complex formulations that will truly impact health. Our team has worked extensively to ensure that our innovation was truly unique to the market, and most importantly, that it would have a tremendous impact on those with a vision for what the market needs.”
